Consensus ESG Ratings
Member Sign In
ESG News For Castle Biosciences Inc
These sites contributed news to this page:
-
Flinn Foundation-Sponsored Study Identifies Three Bioscience Growth Areas to Advance Innovation and Economic Growth in Greater Phoenix
Precision oncology/medicine, digital health, translational neurosciences to advance Phoenix Bioscience Core, new hubs -
Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event
Thirteen sunscreen dispensers, positioned at rest and lunch stops, will supply sunscreen to the more than 5,200 riders to protect their skin from sunburn during the two-day event -
Castle Biosciences Recognizes Skin Cancer Awareness Month through Its Support of Patient-Focused Initiatives
Castle is proud to collaborate with the Melanoma Research Foundation and The Skin Cancer Foundation in support of key advocacy events during the month of May -
Castle Biosciences Releases Inaugural Environmental, Social and Governance (ESG) Report
Report affirms Castle’s commitment to ESG principles and serves as a benchmark for future progress -
Castle Biosciences Supports the American Skin Association with Research Grant
The ASA Castle Biosciences Research Grant Melanoma was awarded to Joel Sunshine, M.D., Ph.D., Johns Hopkins School of Medicine -
Castle Biosciences Supports American Academy of Dermatology's "Skin Cancer, Take a Hike!™" Steps Challenge for Skin Cancer Awareness Month
The month-long fundraising event invites the public to help log 9,500 miles in honor of the approximately 9,500 people diagnosed with skin cancer every day